6.6 Gonadotrophin responsive conditions
Gender Incongruence / Gender Dysphoria
In March 2024, NHSE published their commissioning position for puberty suppressing hormones (PSH).
PSHs are synthetic (man-made) hormones that suppress the hormones naturally produced by the body and in doing so, suppress puberty, with the aim of reducing the level of puberty-related anxiety in an individual with gender incongruence.
PSHs are not available as a routine commissioning treatment option for treatment of children and young people who have gender incongruence/dysphoria.
NHSE have concluded that there is insufficient evidence to support the safety or clinical effectiveness of PSH to make these treatments routinely available at this time.
For Angioedema (Unlicensed) - Coastal West Sussex ONLY
Pack |
---|
100 capsule |
60 capsule |
28 capsule |
1 capsule |
Pack |
---|
60 capsule |
100 capsule |
56 capsule |
1 capsule |
For Gender Dysphoria see chapter 6.8.3 Gender Incongruence
PURPLE - All other indications.
Pack |
---|
1 pre-filled disposable injection |
Pack |
---|
1 pre-filled disposable injection |
For Gender Dysphoria see chapter 6.8.3 Gender Incongruence
PURPLE - All other indications.
Pack |
---|
1 pre-filled disposable injection |
Pack |
---|
1 vial |
Pack |
---|
1 pre-filled disposable injection |
Pack |
---|
1 vial |
Pack |
---|
1 pre-filled disposable injection |
Pack |
---|
1 vial |
For Gender Dysphoria see chapter 6.8.3 Gender Incongruence
PURPLE - All other indications.
Please note: there are differences in licensed indications for each strength, review SPC for individual products for further information. For the treatment of precocious puberty only strengths 3.75mg , 11.25mg and 22.5mg are licensed for this indication. (GP’s should not be asked to prescribe 3.75mg by secondary care).
Pack |
---|
1 vial |
Pack |
---|
1 pre-filled disposable injection |
Pack |
---|
1 vial |
Pack |
---|
1 vial |